Clinical data | |
---|---|
Trade names | Picato |
Other names | PEP005, ingenol-3-angelate |
AHFS/Drugs.com | Monograph |
MedlinePlus | a613008 |
Pregnancy category |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | not absorbed when used topically |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.214.695 |
Chemical and physical data | |
Formula | C25H34O6 |
Molar mass | 430.541 g·mol−1 |
3D model (JSmol) | |
| |
|
Ingenol mebutate, sold under the brand name Picato, is a substance that is found in the sap of the plant Euphorbia peplus,[1] commonly known as petty spurge, and is an inducer of apoptosis. This compound was isolated first from this plant in 2000.[2] A gel formulation of the drug has been approved by the U.S. Food and Drug Administration (FDA)[3] and by the European Medicines Agency (EMA)[4] for the topical treatment of actinic keratosis. Two different strengths of the gel have been approved for use on either the face and scalp (0.015%) or the trunk and extremities (0.05%), respectively.[5] In 2020 the drug was withdrawn from the market in the EU.[6]
Fallen
was invoked but never defined (see the help page).Drugs@FDA
was invoked but never defined (see the help page).EMA
was invoked but never defined (see the help page).Approved label
was invoked but never defined (see the help page).EMA-withdrawal
was invoked but never defined (see the help page).